Tag: Acromegaly
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery,...
Chiasma Presents New Positive Data for MYCAPSSA from Phase 3 Trial...
--Data supports MYCAPSSA® as non-inferior to long-acting injectable somatostatin receptor ligands (iSRLs)-- --Data demonstrated patients taking MYCAPSSA had significant improvement in acromegaly...